# Health markers, depressive symptoms, and community deprivation in a type 2 diabetes multidisciplinary care clinic for youth

**Authors:** Carolina M. Bejarano, Sanita Ley, Nisha Krishnan, Sarah Orkin, Nancy A. Crimmins, Lisa Schaaf, Amy S. Shah

PMC · DOI: 10.1186/s40842-024-00180-x · 2024-07-17

## TL;DR

This study explores how race, ethnicity, and community deprivation affect health and depressive symptoms in youth with type 2 diabetes.

## Contribution

The study identifies racial/ethnic and socioeconomic disparities in metabolic health and depressive symptoms among youth with type 2 diabetes.

## Key findings

- Hispanic/Latino youth had higher liver enzymes compared to non-Hispanic/Latino Black youth at initial visits.
- Youth in higher socioeconomic deprivation areas showed improved hemoglobin A1C over time.
- Depressive symptoms increased in Black and Hispanic youth but decreased in non-Hispanic White youth.

## Abstract

Type 2 diabetes disproportionately affects non-Hispanic/Latino Black and Hispanic/Latino youth. The purpose of this study was to examine whether differences in metabolic risk factors and depressive symptoms exist by race/ethnicity and socioeconomic deprivation and whether these impact clinic attendance and health markers over 1 year in a multidisciplinary type 2 diabetes clinic for youth.

This study was a retrospective chart review of 54 youth with type 2 diabetes who had both an initial and follow-up visit. Demographic information, metabolic health markers [body mass index (BMI), hemoglobin A1C, liver enzymes, lipid panel, and urine microalbumin], depressive symptoms, and clinic attendance data were obtained from the medical record. Patient address was geocoded to the census tract level to calculate community socioeconomic deprivation.

Liver enzymes (ALT and AST) were significantly higher in patients identifying as Hispanic/Latino (ALT M = 97.0 ± 40.6, AST M = 53.6 ± 21.4) and lowest in patients identifying as non-Hispanic/Latino Black (ALT M = 23.1 ± 11.3, F = 10.6 p < .001; AST M = 23.1 ± 11.4, F = 8.1; p < .001) at initial visit. From initial visit to follow-up, there were significant improvements in ALT (F = 13.43, p < .001), AST (F = 6.58, p < .05), and BMIz (F = 18.39, p < .001). Patients identifying as Black or Hispanic showed an increase in depressive symptoms over time, while patients identifying as non-Hispanic White showed a decrease (F = 11.08; p < .05). Unexpectedly, patients living in areas with higher socioeconomic deprivation showed a decrease in hemoglobin A1C over time, while patients living in lower socioeconomic deprivation showed an increase (F = 5.15, p < .05).

Differences exist in metabolic health parameters by race/ethnicity and by socioeconomic deprivation. Multidisciplinary care for youth with type 2 diabetes needs to consider and work to address the systems of inequity experienced by patients that drive disparities in health outcomes.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}
- **Diseases:** depressive symptoms (MESH:D003866), Type 2 diabetes (MESH:D003924)
- **Chemicals:** lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A1C

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11253452/full.md

---
Source: https://tomesphere.com/paper/PMC11253452